PASSReviewer 1· 90% conf
The paper is transparently reported with a trial registration, reference to CONSORT, discussion of limitations, and proportional conclusions, though the trial registration number is only in the abstract and data statement.
Evidence
direct quote[Abstract; Methods, Trial design and ethical approval]
“ClinicalTrials.gov: NCT06025942”direct quote[Methods, Trial design and ethical approval]
“This paper was developed in accordance with the CONSORT 2010 checklist”direct quote[Discussion, paragraph 5]
“Results should be interpreted in the context of several limitations.”PASSReviewer 2· 90% conf
The paper is well-reported with a trial registration, adherence to CONSORT, discussion of limitations, and proportional conclusions, though a formal reporting checklist is not explicitly submitted.
Evidence
direct quote[Abstract]
“ClinicalTrials.gov: NCT06025942”direct quote[Methods, Trial design and ethical approval]
“This paper was developed in accordance with the CONSORT 2010 checklist”direct quote[Discussion, paragraph 6]
“Results should be interpreted in the context of several limitations.”PASSReviewer 3· 90% conf
The manuscript demonstrates high reporting transparency with a clinical trial registration, a CONSORT diagram, detailed methods, limitations discussion, proportional conclusions, and clear funding/COI statements.
Evidence
direct quote[Abstract, Methods]
“ClinicalTrials.gov: NCT06025942 (http://clinicaltrials.gov/study/NCT06025942)”direct quote[Methods, Trial design and ethical approval]
“This paper was developed in accordance with the CONSORT 2010 checklist”direct quote[Discussion, paragraphs 6-7]
“Results should be interpreted in the context of several limitations. First, our design compared Purrble plus safety planning with safety planning alone...”